Lu, Nelson
1493  results:
Search for persons X
?
3

The Elusiveness of the Win Ratio Parameter in the Presence ..:

Li, Heng ; Chen, Wei-Chen ; Lu, Nelson..
Therapeutic Innovation & Regulatory Science.  58 (2024)  3 - p. 431-432 , 2024
 
?
4

The Finkelstein–Schoenfeld Test: A Note on Some Overlooked ..:

Tang, Rong ; Chen, Wei-Chen ; Li, Heng..
Therapeutic Innovation & Regulatory Science.  58 (2024)  3 - p. 465-472 , 2024
 
?
 
?
 
?
7

Some Thoughts on the Use of Predictive Probability in Clini..:

Li, Heng ; Buzoianu, Manuela ; Chakraborty, Adrijo...
Therapeutic Innovation & Regulatory Science.  57 (2023)  3 - p. 464-466 , 2023
 
?
 
?
9

Improving precision and power in randomized trials with a t..:

Ye, Xuan ; Lu, Nelson ; Xu, Yunling
Pharmaceutical Statistics.  22 (2022)  2 - p. 396-407 , 2022
 
?
10

Rejoinder to Letter to the Editor—Selecting an Optimal Desi..:

Lu, Nelson ; Xu, Yunling ; Yue, Lilly Q.
Statistics in Biopharmaceutical Research.  14 (2022)  2 - p. 265-267 , 2022
 
?
12

Successful treatment of suspected early form of chronic Cha..:

Lu, Nelson ; Werry, Denise ; Chapman, Michael...
European Heart Journal - Case Reports.  6 (2022)  10 - p. , 2022
 
?
13

Propensity score-integrated approach to survival analysis: ..:

Chen, Wei-Chen ; Lu, Nelson ; Wang, Chenguang...
Journal of Biopharmaceutical Statistics.  32 (2022)  3 - p. 400-413 , 2022
 
?
15

Mitigating Study Power Loss Caused by Clinical Trial Disrup..:

Li, Heng ; Chen, Wei-Chen ; Lu, Nelson...
Statistics in Biopharmaceutical Research.  14 (2021)  1 - p. 87-91 , 2021
 
1-15